146 related articles for article (PubMed ID: 32883157)
21. [Efficacy of ACE-inhibitors in patients with recent myocardial infarction. Studies with zofenopril].
Lombardi C; Castrini AI; Metra M; Carubelli V; Lazzarini V; Inama L; Dei Cas L
G Ital Cardiol (Rome); 2012 Oct; 13(10 Suppl 2):55S-58S. PubMed ID: 23096377
[TBL] [Abstract][Full Text] [Related]
22. Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study.
Borghi C; Cicero AF; Ambrosioni E
Vasc Health Risk Manag; 2008; 4(3):665-71. PubMed ID: 18827916
[TBL] [Abstract][Full Text] [Related]
23. Effects of the early administration of zofenopril on onset and progression of congestive heart failure in patients with anterior wall acute myocardial infarction. The SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation.
Borghi C; Ambrosioni E; Magnani B
Am J Cardiol; 1996 Aug; 78(3):317-22. PubMed ID: 8759812
[TBL] [Abstract][Full Text] [Related]
24. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators.
Ambrosioni E; Borghi C; Magnani B
N Engl J Med; 1995 Jan; 332(2):80-5. PubMed ID: 7990904
[TBL] [Abstract][Full Text] [Related]
25. Long-term clinical experience with zofenopril.
Borghi C; Bacchelli S; Degli Esposti D
Expert Rev Cardiovasc Ther; 2012 Aug; 10(8):973-82. PubMed ID: 23030285
[TBL] [Abstract][Full Text] [Related]
26. Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation.
Borghi C; Bacchelli S; Esposti DD; Bignamini A; Magnani B; Ambrosioni E
Am J Hypertens; 1999 Jul; 12(7):665-72. PubMed ID: 10411363
[TBL] [Abstract][Full Text] [Related]
27. Zofenopril Protects Against Myocardial Ischemia-Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability.
Donnarumma E; Ali MJ; Rushing AM; Scarborough AL; Bradley JM; Organ CL; Islam KN; Polhemus DJ; Evangelista S; Cirino G; Jenkins JS; Patel RA; Lefer DJ; Goodchild TT
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381758
[TBL] [Abstract][Full Text] [Related]
28. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
Pasini AF; Garbin U; Nava MC; Stranieri C; Pellegrini M; Boccioletti V; Luchetta ML; Fabrizzi P; Lo Cascio V; Cominacini L
Am J Hypertens; 2007 Apr; 20(4):443-50. PubMed ID: 17386354
[TBL] [Abstract][Full Text] [Related]
29. Serum cholesterol levels on admission and survival in patients with acute myocardial infarction treated with zofenopril: a post hoc analysis of the Survival of Myocardial Infarction Long-term Evaluation trial.
Borghi C; Cicero AF; Bacchelli S; Esposti DD; Ambrosioni E;
Fundam Clin Pharmacol; 2009 Oct; 23(5):641-8. PubMed ID: 19656211
[TBL] [Abstract][Full Text] [Related]
30. Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.
van Wijngaarden J; Pinto YM; van Gilst WH; de Graeff PA; de Langen CD; Wesseling H
Cardiovasc Res; 1991 Nov; 25(11):936-42. PubMed ID: 1813122
[TBL] [Abstract][Full Text] [Related]
31. [Effects of ramipril and spironolactone on ventricular remodeling after acute myocardial infarction: randomized and double-blind study].
Rodríguez JA; Godoy I; Castro P; Quintana JC; Chávez E; Yovanovich J; Corbalán R; Chávez A
Rev Med Chil; 1997 Jun; 125(6):643-52. PubMed ID: 9515282
[TBL] [Abstract][Full Text] [Related]
32. Cardioprotective role of zofenopril in patients with acute myocardial infarction: a pooled individual data analysis of four randomised, double-blind, controlled, prospective studies.
Borghi C; Omboni S; Reggiardo G; Bacchelli S; Degli Esposti D; Ambrosioni E
Open Heart; 2015; 2(1):e000220. PubMed ID: 26380097
[TBL] [Abstract][Full Text] [Related]
33. A review of the angiotensin-converting enzyme inhibitor, zofenopril, in the treatment of cardiovascular diseases.
Borghi C; Bacchelli S; Degli Esposti D; Ambrosioni E
Expert Opin Pharmacother; 2004 Sep; 5(9):1965-77. PubMed ID: 15330734
[TBL] [Abstract][Full Text] [Related]
34. Treatment with ramipril improves systolic function even in patients with mild systolic dysfunction and symptoms of heart failure after acute myocardial infarction.
Kongstad-Rasmussen O; Blomstrand P; Broqvist M; Dahlström U; Wranne B
Clin Cardiol; 1998 Nov; 21(11):807-11. PubMed ID: 9825192
[TBL] [Abstract][Full Text] [Related]
35. Effects of early angiotensin-converting enzyme inhibition in patients with non-ST-elevation acute anterior myocardial infarction.
Borghi C; Bacchelli S; Degli Esposti D; Ambrosioni E;
Am Heart J; 2006 Sep; 152(3):470-7. PubMed ID: 16923416
[TBL] [Abstract][Full Text] [Related]
36. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.
Lancet; 1993 Oct; 342(8875):821-8. PubMed ID: 8104270
[TBL] [Abstract][Full Text] [Related]
37. Effects of the early ACE inhibition in diabetic nonthrombolyzed patients with anterior acute myocardial infarction.
Borghi C; Bacchelli S; Esposti DD; Ambrosioni E;
Diabetes Care; 2003 Jun; 26(6):1862-8. PubMed ID: 12766124
[TBL] [Abstract][Full Text] [Related]
38. Early administration of ramipril in acute myocardial infarction: neurohormonal and hemodynamic effects and tolerability.
van der Ent M; Remme WJ; Bartels GL; Kruijssen DA; Krauss XH; van Hoogenhuyze DC
Cardiology; 1997; 88(6):548-55. PubMed ID: 9397311
[TBL] [Abstract][Full Text] [Related]
39. Effect of endostatin and insulin-like growth factor-1 on angiogenesis in patients with acute myocardial infarction with obesity under the influence of zofenopril.
Martovytskyi DV; Shelest OM; Kravchun PG
Wiad Lek; 2020; 73(1):63-67. PubMed ID: 32124808
[TBL] [Abstract][Full Text] [Related]
40. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
